Consonance Capital Home Private Equity Hedge Fund Contact Consonance Capital Healthcare Investors Consonance Capital, founded and led by CEO, Mitchell Blutt, MD, is a healthcare investment platform. Public life sciences investments are made under the direction of Consonance Capital Management, a hedge fund manager founded by Mitchell Blutt, MD, and his co-founders, Kevin Livingston and Benny Soffer, MD. Consonance Life Sciences, an affiliate of Consonance Capital Management, is the sponsor of Consonance-HFW Acquisition Corporation, a Special Purpose Acquisition Company, whose management team is focused on identifying and acquiring a private biotechnology company that will then become public. Private equity investments, which include growth equity, leveraged buyouts, and recapitalizations, are made under the direction of Consonance Capital Partners, a private equity manager co-founded and co-led by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. The Consonance Capital platform was created in 2005. Consonance Capital (212) 660-8060 1370 6th Ave 33rd floor, New York, NY 10019, USA ©2021 by Consonance Capital.

Consonance Capital Management Overview Team Contact More Consonance Capital Management Investment Team Mitchell Blutt, MD Consonance Capital CEO and Founder Benny Soffer, MD Co-Founder and Partner CIO, Portfolio Manager Kevin H. Livingston Co-Founder, Partner, President and Chief Operating Officer Reza Keshavarz, MD Partner Director of Therapeutics Damien Nguyen Senior Analyst Eric Fischer Senior Analyst Compliance, Finance, Trading, Marketing & Operations Maria de León Chief Compliance Officer Gabriela J. Franco-Boland Chief Financial Officer Gary Garofalo Head Trader Michael Feeney Head of Marketing & Investor Relations Brianne Shergill Operations Manager Jae Park Assistant Controller Consonance Capital Management (212) 660-8060 1370 6th Ave, 33rd floor New York, NY 10019, USA info@consonancecapital.com ©2021 by Consonance Capital Management.